Goodwin, G.M. and Haddad, P.M. and Ferrier, I.N. and Aronson, J.K. and Barnes, T.R.H. and Cipriani, A. and Coghill, D.R. and Fazel, S. and Geddes, J.R. and Grunze, H. and Holmes, E.A. and Howes, O. and Hudson, S. and Hunt, N. and Jones, I. and Macmillan, I.C. and McAllister-Williams, H. and Miklowitz, D.M. and Morriss, Richard K. and Munafo, M. and Paton, C. and Saharkian, B.J. and Saunders, K.E.A. and Sinclair, J.M.A. and Taylor, D. and Vieta, E. and Young, A.
Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology.
Journal of Psychopharmacology
The British Association for Psychopharmacology guidelines specify the scope and targets of treatment for bipolar disorder. The third version is based explicitly on the available evidence and presented, like previous Clinical Practice Guidelines, as recommendations to aid clinical decision making for practitioners: it may also serve as a source of information for patients and carers, and assist audit. The recommendations are presented together with a more detailed review of the corresponding evidence. A consensus meeting, involving experts in bipolar disorder and its treatment, reviewed key areas and considered the strength of evidence and clinical implications. The guidelines were drawn up after extensive feedback from these participants. The best evidence from randomized controlled trials and, where available, observational studies employing quasi-experimental designs was used to evaluate treatment options. The strength of recommendations has been described using the GRADE approach. The guidelines cover the diagnosis of bipolar disorder, clinical management, and strategies for the use of medicines in short-term treatment of episodes, relapse prevention and stopping treatment.The use of medication is integrated with a coherent approach to psychoeducation and behaviour change.
||Bipolar disorder, treatment, evidence-based guidelines, antipsychotics, antidepressants, mood stabilizers, lithium, psychoeducation, cognitive behaviour therapy
||University of Nottingham UK Campus > Faculty of Medicine and Health Sciences > School of Medicine > Division of Psychiatry
||24 Mar 2016 15:20
||13 Sep 2016 14:46
Actions (Archive Staff Only)